Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/30/2010CN101544661B Cefobutazine sodium compound and pharmaceutical composition made therefrom
06/30/2010CN101537172B Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same
06/30/2010CN101338045B Technique of preparing cassava starch plant gum, the plant gum prepared thereby and plant capsules
06/30/2010CN101332188B Method for preparing powder injection using attritioning technique and prepared products
06/30/2010CN101322848B Composition for gastroscopy and preparation thereof
06/30/2010CN101317852B Powder injection of compound glycyrrhizic acid glycosides and preparation method thereof
06/30/2010CN101292987B Pharmaceutical combination
06/30/2010CN101283999B Medicinal composition mainly for curing cardiovascular and cerebrovascular diseases and preparation method thereof
06/30/2010CN101269183B Externally applied medicament for treating exogenous injury of athletes
06/30/2010CN101265264B Method for producing high-purity mezlocillin sodium and powder injection thereof
06/30/2010CN101244045B Zero level drug administration oral controlled-release tablet and preparation thereof
06/30/2010CN101224287B Oral administration Chinese traditional medicine for treating acne and preparing method thereof
06/30/2010CN101129817B Chinese medicine formulation for treating hypertension and method of producing the same
06/30/2010CN101095895B Externally-used medicament for the sanitation and health-care of female vagina and for treating gynecology vagina diseases and method for making the same
06/30/2010CN101084874B Method for preparing water soluble hypocrellin silica nanometer particle and its application in preparing venous injection
06/30/2010CN101077343B Dexibuprofen granule and preparation method thereof
06/30/2010CN101024006B Chinese medicine for treating gallstones
06/29/2010USRE41408 pharmacokinetics; opioid addiction
06/29/2010US7745651 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity
06/29/2010US7745497 Electrostatic aerosol compositions
06/29/2010US7744945 Drug encapsulated with vacuum formed film
06/29/2010US7744925 Insulin and a sugar alcohol; powder for pulmonary delivery; inhalants; storage stability
06/29/2010US7744924 Multi-particulate oral dosage form
06/29/2010US7744923 Lyophobic precipitation of liquid-dispersed or dissolved material using antisolvent gas at near-supercritical or supercritical conditions
06/29/2010US7744922 Film forming envelope encloding core; food, drugs, oral hygiene, cosmetics
06/29/2010US7744921 Liposome loading with metal ions
06/29/2010US7744920 Glucocoricoid is an amphipathic weak acid or base such as methylprednisolone sodium hemisuccinate encapsulated in a liposome; treating rheumatoid arthritis or other autoimmune disease, provided they are not neurodegenerative disorders
06/29/2010US7744919 Block copolymer micelle composition having an enhanced drug-loading capacity and sustained release
06/29/2010US7744918 Drug-containing patch
06/29/2010US7744916 Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
06/29/2010US7744915 Apparatus and method for preventing adhesions between an implant and surrounding tissues
06/29/2010US7744912 Forming a biopolymer by polymerization or crosslinking through self-selective reaction between a strong multifunctional nucleophile such as amine or thiol and a conjugated unsaturated bond; preparation of highly biomimetic synthetic polymers
06/29/2010US7744910 Compounds and compositions for delivering active agents
06/29/2010US7744909 Dispersions for the formulation of slightly or poorly soluble agents
06/29/2010US7744908 Allowing full spoon filling for accurate pharmaceutical dosage; storage stability
06/29/2010US7744904 Stabilization of Clostridium botulinum neurotoxin complex
06/29/2010US7744858 Containing a sulphonic group, in free form or partially or totally neutralized form and comprising at least one hydrophobic portion; used in cosmetics
06/29/2010US7744857 Antiperspirant compositions
06/29/2010US7744855 Milling particles for use in inhalable pharmaceuticals
06/29/2010US7744852 Device for marking a cavity in a breast for subsequent visualization including a delivery opening, first and second markers movable through opening, visualized by ultrasound and radiopacity; percutaneous minimally invasive large intact tissue sample collection; inserts; positioning;
06/29/2010US7744589 Infusion medium delivery device and method with drive device for driving plunger in reservoir
06/29/2010US7744556 Delivery tube assembly for an applicator
06/29/2010CA2636421C A method of platelet and whole blood storage
06/29/2010CA2538856C Transdermal pharmaceutical formulation for minimizing skin residues
06/29/2010CA2526464C A rupturing controlled release device having a preformed passageway
06/29/2010CA2504065C Dispersible antibacterial pharmaceutical compositions
06/29/2010CA2461576C Process for the preparation of tablets comprising s-adenosylmethionine
06/29/2010CA2453117C Oral dosage forms comprising a benzimidazole and buffer
06/29/2010CA2452471C Enhancement of transfection of dna into the liver
06/29/2010CA2448273C Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
06/29/2010CA2444733C Packaging system for transdermal drug delivery systems
06/29/2010CA2424596C Oral self-emulsifying formulations of pyranone protease inhibitors
06/29/2010CA2418070C Hybrid neuroprosthesis for the treatment of brain disorders
06/29/2010CA2415280C Use of halogenated xanthenes as anti-cancer and anti-bacterial agents
06/29/2010CA2406373C Controlled release paracetamol composition
06/29/2010CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
06/29/2010CA2401942C Pharmaceutical compositions for buccal and pulmonary application
06/29/2010CA2387746C Methods for stabilizing benzimidazole-based compounds
06/29/2010CA2382389C Pharmaceutically stable oxaliplatinum preparation for parenteral administration
06/29/2010CA2379734C Treatment of cancers
06/29/2010CA2378682C Cooking/drying process for amylose-rich starches
06/29/2010CA2370225C Highly purified gonadotropin compositions and process for preparing them
06/29/2010CA2357114C Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
06/29/2010CA2355814C Pharmaceutical composition for ophthalmic use
06/29/2010CA2350396C A composition useful to treat periodontal disease
06/29/2010CA2336593C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
06/29/2010CA2257837C Long-acting galenical formulation for grf peptides
06/29/2010CA2195169C Transfection competent molecules
06/24/2010WO2010071593A1 Delivery system for delivery of a substance into the oral cavity
06/24/2010WO2010071321A2 ORAL FORMULATIONS CONTAINING METFORMIN AND α-GLYCOSIDASE INHIBITOR, AND PREPARATION METHOD THEREOF
06/24/2010WO2010071320A2 Controlled-release composition for producing sustained-release preparation containing udenafil
06/24/2010WO2010071313A2 Granules containing lacidipine, and pharmaceutical compositions comprising same
06/24/2010WO2010071232A1 A disintegrating tablet
06/24/2010WO2010071230A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
06/24/2010WO2010071207A1 Adhesive tape manufacturing method and adhesive tape
06/24/2010WO2010071104A1 Pressure-sensitive adhesive tape package
06/24/2010WO2010070705A1 Aqueous oral preparation of stable amlodipine
06/24/2010WO2010070664A1 Curcuminoids and its metabolites for the application in ocular diseases
06/24/2010WO2010070618A2 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus
06/24/2010WO2010070617A1 Inclusion complexes of alpha-cyclodextrin and sildenafil salt
06/24/2010WO2010070611A1 Atazanavir formulations
06/24/2010WO2010070589A2 A novel dermaceutical cream made using sodium fusidate
06/24/2010WO2010070210A1 Pharmaceutical composition containing an n-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control
06/24/2010WO2010070141A2 Compositions comprising adipose stem cells
06/24/2010WO2010070132A1 Thioic acids as building block for polythioesters
06/24/2010WO2010070097A1 Method for producing n-vinyl pyrrolidone/vinyl acetate copolymers
06/24/2010WO2010070091A1 Oral dispersible tablet
06/24/2010WO2010070090A1 Solid composition containing the ingredient rasagiline
06/24/2010WO2010070057A2 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
06/24/2010WO2010070028A1 Melt-coated pharmaceutical composition with fast release
06/24/2010WO2010070023A2 Formulations
06/24/2010WO2010069795A2 Capecitabine rapidly disintegrating tablets
06/24/2010WO2010069621A1 Treatment of vaginal atrophy in women with cardiovascular pathology risk
06/24/2010WO2010069595A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
06/24/2010WO2010069519A1 Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
06/24/2010WO2010069311A1 Multi-part kit
06/24/2010WO2010069141A1 A controlled-released osmotic pump tablet with lubricating layer and the preparation thereof
06/24/2010WO2010069139A1 Pharmaceutical composition and preparation method thereof
06/24/2010WO2010069138A1 Oryzanol composition and preparation method thereof
06/24/2010WO2010069050A1 Misuse preventative, controlled release formulation
1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 2991